RussellHSwerdlowMD

Director of the University of Kansas Alzheimer's Disease Center and the KUMC Neurodegenerative Disorders Program. Professor in the Departments of Neurology, Molecular and Integrative Physiology; and Biochemistry and Molecular Biology, University of Kansas School of Medicine.

Join to view full profile

Dr. Swerdlow is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Swerdlow's full profile

Already have an account?

Office
4350 Shawnee Mission Pkwy
Fairway, KS 66205
Phone+1 913-588-0000

Fax+1 913-945-7508

Education & Training

New York University School of MedicineClass of 1991

Certifications & Licensure

KS State Medical License 2007 - 2025
MO State Medical License 2021 - 2025
VA State Medical License 1994 - 2024
American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

Oxaloacetate Pharmacokinetics and Safety Start of enrollment: 2014 Feb 01
Completed
Not Applicable
S-Equol in Alzheimer's Disease (SEAD) Trial Start of enrollment: 2014 Jul 01
Completed
Phase 1

Publications & Presentations

PubMed

535 citations
The Alzheimer's disease mitochondrial cascade hypothesis: progress and perspectives.
Russell H. Swerdlow, Jeffrey M. Burns, Shaharyar M. Khan
Biochimica Et Biophysica Acta. 2014-08-01
733 citations
Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis
Yasser Iturria-Medina, Roberto C. Sotero, Paule-Joanne Toussaint, José María Mateos-Pérez, Alan C. Evans
Nature Communications. 2016-06-21
143 citations
Inhibition of ERK-DLP1 signaling and mitochondrial division alleviates mitochondrial dysfunction in Alzheimer's disease cybrid cell
Xueqi Gan, Shengbin Huang, Long Wu, Yongfu Wang, Gang Hu
Biochimica Et Biophysica Acta. 2014-02-01

Press Mentions

Regular Use of Laxatives May Increase Risk by 51%February 24th, 2023
Regular Laxative Use Linked to Increased Dementia RiskFebruary 23rd, 2023
Alzheimer's: Can a Blood Test Detect Disease 3.5 Years Before Diagnosis?January 31st, 2023
Join now to see all

Grant Support

Oxaloacetate'S Brain EffectsNational Institute Of Neurological Disorders And Stroke2012
University Of Kansas Alzheimer'S Disease Core CenterNational Institute On Aging2011
Neuropathology CoreNational Institute On Aging2011
Neuroimaging CoreNational Institute On Aging2011
Mitochondrial Genomics And Metabolism CoreNational Institute On Aging2011
Education And Information Transfer CoreNational Institute On Aging2011
Data Management And Statistics CoreNational Institute On Aging2011
Clinical CoreNational Institute On Aging2011
Administrative CoreNational Institute On Aging2011
Cytochrome Oxidase Polymorphisms In AgingNational Institute On Aging2007
Cytochrome Oxidase Polymorphisms In AgingNational Institute On Aging2005–2007
Pathophysiology In NeurodegenerationNational Institute On Aging1998–2002